| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701684 | Journal of Thoracic Oncology | 2017 | 33 Pages |
Abstract
ROS1-positive metastatic lung adenocarcinomas frequently harbor concomitant oncogenic driver mutations. Levels of ROS1 FISH-positive events are variable over time. This heterogeneity provides additional therapeutic options if discovered by multiplex biomarker testing and repeat biopsies.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Marcel MD, Wilfried E.E. MD, Henning MD, Saskia MD, Nikoleta Savvidou, Charlotte Skiba, Thomas PhD, Daniel C. MD, Johannes MD, Karl PhD, Stefan MD, Dirk MD, Jörg MD, Thomas MD, Kaid MD, Filiz MD, Clemens MD, Stefan MD, Martin MD,